Literature DB >> 30160510

Race analysis in an African American sample with serious mental illness and comorbid diabetes.

Martha Sajatovic1, Molly Howland1, Douglas Gunzler2, Stephanie W Kanuch3, Kristin A Cassidy4, Richard McCormick5, Mark S Bauer6, Thomas Scheidemantel7, Charles Thomas8, Carol Blixen9, Neal V Dawson2.   

Abstract

OBJECTIVES: Targeted Training in Illness Management (TTIM) focuses on enhancing care engagement for people living with serious mental illness and diabetes. This secondary analysis from a 60-week, randomized controlled trial of TTIM versus treatment as usual evaluated racial subgroup outcomes.
METHOD: Demographics, clinical characteristics, and diabetes status were evaluated for those self-identifying as non-Hispanic White, African American, and Hispanic. Longitudinal response to TTIM was evaluated using a multiple domain risk index. Due to their small sample size; those identifying as Hispanic were excluded from this analysis.
RESULTS: Non-Hispanic White participants had greater baseline socioeconomic advantages. Baseline risk scores, glycosylated hemoglobin (HbA1c) values, and HbA1c differences over time were similar for African American and non-Hispanic White participants. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: African American participants living with serious mental illness and diabetes receiving TTIM did as well as non-Hispanic White participants. Inclusive approaches that feature peer support and are situated in safety-net health care settings need to be further investigated with respect to potentially impacting health disparities. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30160510      PMCID: PMC6442459          DOI: 10.1037/prj0000314

Source DB:  PubMed          Journal:  Psychiatr Rehabil J        ISSN: 1095-158X


  30 in total

Review 1.  Lessons learned about minority recruitment and retention from the Centers on Minority Aging and Health Promotion.

Authors:  Sue Levkoff; Herman Sanchez
Journal:  Gerontologist       Date:  2003-02

2.  Racial/Ethnic disparities in monitoring metabolic parameters for patients with schizophrenia receiving antipsychotic medications.

Authors:  Karon L Phillips; Laurel A Copeland; John E Zeber; Eileen M Stock; Jack Y Tsan; Andrea A MacCarthy
Journal:  Am J Geriatr Psychiatry       Date:  2014-07-30       Impact factor: 4.105

Review 3.  Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications.

Authors:  Guy Faulkner; Tony A Cohn
Journal:  Can J Psychiatry       Date:  2006-07       Impact factor: 4.356

4.  A 60-Week Prospective RCT of a Self-Management Intervention for Individuals With Serious Mental Illness and Diabetes Mellitus.

Authors:  Martha Sajatovic; Douglas D Gunzler; Stephanie W Kanuch; Kristin A Cassidy; Curtis Tatsuoka; Richard McCormick; Carol E Blixen; Adam T Perzynski; Douglas Einstadter; Charles L Thomas; Mary E Lawless; Siobhan Martin; Corinna Falck-Ytter; Eileen L Seeholzer; Christine L McKibben; Mark S Bauer; Neal V Dawson
Journal:  Psychiatr Serv       Date:  2017-05-15       Impact factor: 3.084

5.  Mortality and medical comorbidity among patients with serious mental illness.

Authors:  Brian J Miller; C Bayard Paschall; Dale P Svendsen
Journal:  Psychiatr Serv       Date:  2006-10       Impact factor: 3.084

6.  Integrated IMR for psychiatric and general medical illness for adults aged 50 or older with serious mental illness.

Authors:  Stephen J Bartels; Sarah I Pratt; Kim T Mueser; John A Naslund; Rosemarie S Wolfe; Meghan Santos; Haiyi Xie; Erik G Riera
Journal:  Psychiatr Serv       Date:  2014-03-01       Impact factor: 3.084

Review 7.  Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review.

Authors:  Christina Mangurian; John W Newcomer; Chelsea Modlin; Dean Schillinger
Journal:  J Gen Intern Med       Date:  2016-05-05       Impact factor: 5.128

8.  Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis.

Authors:  Rodney A Hayward; David M Kent; Sandeep Vijan; Timothy P Hofer
Journal:  BMC Med Res Methodol       Date:  2006-04-13       Impact factor: 4.615

9.  Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study.

Authors:  Stephen R Benoit; Regina Fleming; Athena Philis-Tsimikas; Ming Ji
Journal:  BMC Public Health       Date:  2005-04-17       Impact factor: 3.295

10.  Chronic illness with complexity: implications for performance measurement of optimal glycemic control.

Authors:  Pramod Meduru; Drew Helmer; Mangala Rajan; Chin-Lin Tseng; Leonard Pogach; Usha Sambamoorthi
Journal:  J Gen Intern Med       Date:  2007-12       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.